Novacyt FY16 financial results PR ENG Paris, France and Cambridge, UK – 27 April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its financial results for the year ended 31 December 2016.
Visit PageAuthor: novacyt
Novacyt Announces Bond Issue
Novacyt – Announces Bond Issue ENG Paris, France and Cambridge, UK – 6th April 2017 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces the Company has issued a convertible bond in the amount of €1,500,000 through the issuance of 1,500,000 bonds which are convertible into shares with a nominal value of
Visit PageMDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
IRVINE, CA, and HERSTAL, BELGIUM – March 21, 2017 – MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a distribution agreement to make its SelectMDx™ for Prostate Cancer test available to Lab21 Clinical Laboratory’s urology clients in the United Kingdom. MDxH-Lab 21 agreement PR ENG
Visit Page